196 related articles for article (PubMed ID: 11935259)
21. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease.
Mohri I; Kadoyama K; Kanekiyo T; Sato Y; Kagitani-Shimono K; Saito Y; Suzuki K; Kudo T; Takeda M; Urade Y; Murayama S; Taniike M
J Neuropathol Exp Neurol; 2007 Jun; 66(6):469-80. PubMed ID: 17549007
[TBL] [Abstract][Full Text] [Related]
23. Hippocampal CA1 cell loss in a non-human primate model of transient global ischemia: a pilot study.
Hara K; Yasuhara T; Matsukawa N; Maki M; Masuda T; Yu G; Xu L; Tambrallo L; Rodriguez NA; Stern DM; Kawase T; Yamashima T; Buccafusco JJ; Hess DC; Borlongan CV
Brain Res Bull; 2007 Sep; 74(1-3):164-71. PubMed ID: 17683803
[TBL] [Abstract][Full Text] [Related]
24. Microglia as a potential bridge between the amyloid beta-peptide and tau.
Kitazawa M; Yamasaki TR; LaFerla FM
Ann N Y Acad Sci; 2004 Dec; 1035():85-103. PubMed ID: 15681802
[TBL] [Abstract][Full Text] [Related]
25. Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels.
Pardon MC; Sarmad S; Rattray I; Bates TE; Scullion GA; Marsden CA; Barrett DA; Lowe J; Kendall DA
Neurobiol Aging; 2009 Jul; 30(7):1099-113. PubMed ID: 18023506
[TBL] [Abstract][Full Text] [Related]
26. Thalidomide inhibition of perturbed vasculature and glial-derived tumor necrosis factor-alpha in an animal model of inflamed Alzheimer's disease brain.
Ryu JK; McLarnon JG
Neurobiol Dis; 2008 Feb; 29(2):254-66. PubMed ID: 17964176
[TBL] [Abstract][Full Text] [Related]
27. Linker histone H1 binds to disease associated amyloid-like fibrils.
Duce JA; Smith DP; Blake RE; Crouch PJ; Li QX; Masters CL; Trounce IA
J Mol Biol; 2006 Aug; 361(3):493-505. PubMed ID: 16854430
[TBL] [Abstract][Full Text] [Related]
28. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits.
Wang Q; Sun AY; Simonyi A; Jensen MD; Shelat PB; Rottinghaus GE; MacDonald RS; Miller DK; Lubahn DE; Weisman GA; Sun GY
J Neurosci Res; 2005 Oct; 82(1):138-48. PubMed ID: 16075466
[TBL] [Abstract][Full Text] [Related]
30. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
Zhang Q; Zhang X; Sun A
Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
[TBL] [Abstract][Full Text] [Related]
31. alpha-Internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury.
Dickson TC; Chuckowree JA; Chuah MI; West AK; Vickers JC
Neurobiol Dis; 2005 Mar; 18(2):286-95. PubMed ID: 15686957
[TBL] [Abstract][Full Text] [Related]
32. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.
Dudal S; Krzywkowski P; Paquette J; Morissette C; Lacombe D; Tremblay P; Gervais F
Neurobiol Aging; 2004 Aug; 25(7):861-71. PubMed ID: 15212840
[TBL] [Abstract][Full Text] [Related]
33. Cerebral ischemia aggravates cognitive impairment in a rat model of Alzheimer's disease.
Li J; Wang YJ; Zhang M; Fang CQ; Zhou HD
Life Sci; 2011 Jul; 89(3-4):86-92. PubMed ID: 21620868
[TBL] [Abstract][Full Text] [Related]
34. Beta-protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients.
van de Nes JA; Konermann S; Nafe R; Swaab DF
Acta Neuropathol; 2006 Feb; 111(2):126-38. PubMed ID: 16456666
[TBL] [Abstract][Full Text] [Related]
35. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
36. PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic, and synaptic structures.
Brendza RP; O'Brien C; Simmons K; McKeel DW; Bales KR; Paul SM; Olney JW; Sanes JR; Holtzman DM
J Comp Neurol; 2003 Feb; 456(4):375-83. PubMed ID: 12532409
[TBL] [Abstract][Full Text] [Related]
37. Expression of pannexin2 protein in healthy and ischemized brain of adult rats.
Zappalà A; Li Volti G; Serapide MF; Pellitteri R; Falchi M; La Delia F; Cicirata V; Cicirata F
Neuroscience; 2007 Sep; 148(3):653-67. PubMed ID: 17692470
[TBL] [Abstract][Full Text] [Related]
38. Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease.
Nagele RG; Wegiel J; Venkataraman V; Imaki H; Wang KC; Wegiel J
Neurobiol Aging; 2004; 25(5):663-74. PubMed ID: 15172746
[TBL] [Abstract][Full Text] [Related]
39. Palmitic and stearic fatty acids induce Alzheimer-like hyperphosphorylation of tau in primary rat cortical neurons.
Patil S; Chan C
Neurosci Lett; 2005 Aug; 384(3):288-93. PubMed ID: 15939536
[TBL] [Abstract][Full Text] [Related]
40. Pathological dynamics of activated microglia following medial forebrain bundle transection.
Cho BP; Song DY; Sugama S; Shin DH; Shimizu Y; Kim SS; Kim YS; Joh TH
Glia; 2006 Jan; 53(1):92-102. PubMed ID: 16206155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
